Comparison of the 2017 ACC/AHA Hypertension Guideline with Earlier Guidelines on Estimated Reductions in Cardiovascular Disease

被引:10
|
作者
Bundy, Joshua D. [1 ,2 ]
Mills, Katherine T. [1 ,2 ]
He, Jiang [1 ,2 ]
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, 1440 Canal St, New Orleans, LA 70112 USA
[2] Tulane Univ, Translat Sci Inst, 1440 Canal St, New Orleans, LA 70112 USA
基金
美国国家卫生研究院;
关键词
Cardiovascular disease; Mortality; Population; Epidemiology; Hypertension guidelines; SYSTOLIC BLOOD-PRESSURE; AGED; 60; YEARS; CLINICAL-PRACTICE; AMERICAN-COLLEGE; J-CURVE; MM HG; METAANALYSIS; EVENTS; ADULTS; OLDER;
D O I
10.1007/s11906-019-0980-5
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Purpose of Review To review the recommendations of the 2017 American College of Cardiology/American Heart Association hypertension guideline and to compare it with previous guidelines on potential cardiovascular disease (CVD) and mortality risk reductions. Recent Findings Compared with previous guidelines, the 2017 hypertension guideline increased the prevalence of hypertension and the number of adults recommended for antihypertensive therapy in the US population. Based on data from recent analyses, the new guideline effectively directs antihypertensive therapy toward individuals at higher CVD risk. Two recent analyses using US national data estimated that implementation of the 2017 hypertension guideline could further reduce hundreds of thousands of CVD events and deaths compared with previous guidelines. However, the new guideline might increase the number of adverse events. The new guideline also improves the number of individuals needed to treat to prevent CVD events and deaths, suggesting implementation is cost-effective. Implementation of the 2017 hypertension guideline is projected to substantially reduce CVD events and deaths in the USA but might increase the number of adverse events. Future research is needed to implement and scale up effective, equitable, and sustainable strategies for applying the new guideline in daily clinical practice.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] ACC/AHA lipid guidelines: Personalized care to prevent cardiovascular disease
    Reiter-Brennan, Cara
    Osei, Albert D.
    Uddin, S. M. Iftekhar
    Orimoloye, Olusola A.
    Obisesan, Olufunmilayo H.
    Mirbolouk, Mohammadhassan
    Blaha, Michael J.
    Dzaye, Omar
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (04) : 231 - 239
  • [42] IMPACTS OF THE NEW 2017 ACC/AHA HYPERTENSION GUIDELINE ON THE PREVALENCE OF BRACHIAL HYPERTENSION AND ITS CONCORDANCE WITH CENTRAL HYPERTENSION
    Chen, C. H.
    Chuang, S. Y.
    Cheng, H. M.
    Chang, H. Y.
    Pan, W. H.
    JOURNAL OF HYPERTENSION, 2018, 36 : E228 - E229
  • [43] The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh
    Al Kibria, Gulam Muhammed
    Swasey, Krystal
    Choudhury, Allysha
    Burrowes, Vanessa
    Stafford, Kristen A.
    Uddin, S. M. Iftekhar
    Mirbolouk, Mohammadhassan
    Sharmeen, Atia
    Angela, K. C.
    Mitra, Dipak K.
    JOURNAL OF HUMAN HYPERTENSION, 2018, 32 (8-9) : 608 - 616
  • [44] The new 2017 ACC/AHA guideline for classification of hypertension: changes in prevalence of hypertension among adults in Bangladesh
    Gulam Muhammed Al Kibria
    Krystal Swasey
    Allysha Choudhury
    Vanessa Burrowes
    Kristen A. Stafford
    S. M. Iftekhar Uddin
    Mohammadhassan Mirbolouk
    Atia Sharmeen
    Angela KC
    Dipak K. Mitra
    Journal of Human Hypertension, 2018, 32 : 608 - 616
  • [45] 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
    Andrus, Bruce
    Lacaille, Diane
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (25) : 2886 - 2886
  • [46] 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary
    Arnett, Donna K.
    Blumenthal, Roger S.
    Albert, Michelle A.
    Buroker, Andrew B.
    Goldberger, Zachary D.
    Hahn, Ellen J.
    Himmelfarb, Cheryl Dennison
    Khera, Amit
    Lloyd-Jones, Donald
    McEvoy, J. William
    Michos, Erin D.
    Miedema, Michael D.
    Munoz, Daniel
    Smith, Sidney C., Jr.
    Virani, Salim S.
    Williams, Kim A., Sr.
    Yeboah, Joseph
    Ziaeian, Boback
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (10) : 1376 - 1414
  • [47] ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy JACC Guideline Comparison
    Capodanno, Davide
    Alfonso, Fernando
    Levine, Glenn N.
    Valgimigli, Marco
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (23) : 2915 - 2931
  • [48] Analysis of Cardiovascular Risk Factors in Newly Defined Stage 1 Hypertension among Chinese on the Basis of the 2017 ACC/AHA Hypertension Guidelines
    Liang Kai
    Wang Chuan
    Yan Fei
    Yang Jun Peng
    Tian Meng
    Wang Ling Shu
    Hou Xin Guo
    Chen Li
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2020, 33 (01) : 48 - 52
  • [49] Stage 1 hypertension defined by the 2017 ACC/AHA Hypertension Guidelines and Risk of Cardiovascular Events: a Cohort Study from Northern China
    Chunpeng Ji
    Shouling Wu
    Jihong Shi
    Zhe Huang
    Chenrui Zhu
    Xin Du
    Shuohua Chen
    Guodong Wang
    Wei Cui
    Hypertension Research, 2019, 42 : 1606 - 1615
  • [50] Analysis of Cardiovascular Risk Factors in Newly Defined Stage 1 Hypertension among Chinese on the Basis of the 2017 ACC/AHA Hypertension Guidelines
    LIANG Kai
    WANG Chuan
    YAN Fei
    YANG Jun Peng
    TIAN Meng
    WANG Ling Shu
    HOU Xin Guo
    CHEN Li
    BiomedicalandEnvironmentalSciences, 2020, 33 (01) : 48 - 52